alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 23.1

            CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement No.
333-16115, No. 333-16117, No. 333-16121, No. 333-44000, No. 333-76631, No.
333-93227, and No. 333-68054 on Form S-8 and in Registration Statements No.
333-85313, No. 333-58202, and No. 333-75146 on Form S-3 of our report dated
March 31, 2005, relating to the financial statements of InteliData Technologies
Corporation (such report expresses an unqualified opinion and includes an
uncertainty paragraph raising substantial doubt about the Company's ability to
continue as a going concern and an explanatory paragraph relating to the
restatement described in Note 2(n)) appearing in this Annual Report on Form 10-K
for the year ended December 31, 2004.

DELOITTE & TOUCHE LLP

McLean, Virginia
March 31, 2005
II 

117TH CONGRESS 

1ST SESSION S. 2885 

To amend the Food, Agriculture, Conservation, and Trade Act of 1990 

to modify the macadamia tree health initiative, and for other purposes. 

IN THE SENATE OF THE UNITED STATES 

SEPTEMBER 29, 2021 

Mr. SCHATZ (for himself and Ms. HIRONO) introduced the following bill; which 

was read twice and referred to the Committee on Agriculture, Nutrition, 

and Forestry 

A BILL 

To amend the Food, Agriculture, Conservation, and Trade 

Act of 1990 to modify the macadamia tree health initiative, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Macadamia Tree 

5 Health Initiative Amendments Act’’. 

6 SEC. 2. MACADAMIA TREE HEALTH INITIATIVE. 

7 Section 1672(d) of the Food, Agriculture, Conserva8 tion, and Trade Act of 1990 (7 U.S.C. 5925(d)) is amend9 ed by striking paragraph (11) and inserting the following: 


kjohnson on DSK79L0C42PROD with BILLS
2 

•S 2885 IS

1 ‘‘(11) MACADAMIA TREE HEALTH INITIATIVE.— 

2 ‘‘(A) DEFINITIONS.—In this paragraph, 

3 the terms ‘noxious weed’ and ‘plant pest’ have 

4 the meanings given those terms in section 403 

5 of the Plant Protection Act (7 U.S.C. 7702). 

6 ‘‘(B) HIGH-PRIORITY RESEARCH AND EX7 TENSION.—Research and extension grants may 

8 be made under this section for the purposes 

9 of— 

10 ‘‘(i) developing and disseminating 

11 science-based tools and treatments to com12 bat plant pests and noxious weeds that im13 pact macadamia trees; 

14 ‘‘(ii) establishing an areawide inte15 grated pest management program in areas 

16 affected by, or areas at risk of being af17 fected by, invasive plant pests or noxious 

18 weeds; 

19 ‘‘(iii) surveying and collecting data on 

20 macadamia tree production and health; 

21 ‘‘(iv) investigating macadamia tree bi22 ology, immunology, ecology, genomics, and 

23 bioinformatics; and 

24 ‘‘(v) conducting research on various 

25 factors that may contribute to or be associVerDate Sep 11 2014 03:08 Sep 30, 2021 Jkt 019200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\S2885.IS S2885

kjohnson on DSK79L0C42PROD with BILLS
3 

•S 2885 IS

1 ated with macadamia tree immune sys2 tems, and other serious threats to maca3 damia trees, including— 

4 ‘‘(I) the sublethal effects of insec5 ticides, herbicides, and fungicides on 

6 beneficial insects and plants to maca7 damia tree growth; and 

8 ‘‘(II) the development of mitiga9 tive and preventative measures to im10 prove habitat conservation and best 

11 management practices in macadamia 

12 tree growing regions. 

13 ‘‘(C) AUTHORIZATION OF APPROPRIA14 TIONS.—There are authorized to be appro15 priated to carry out this paragraph such sums 

16 as are necessary for each of fiscal years 2022 

17 through 2033.’’. 

Æ 


kjohnson on DSK79L0C42PROD with BILLS
# C_2015293EN.01000101.xml

| 5.9.2015 | EN | Official Journal of the European Union | C 293/1 |
| --- | --- | --- | --- |

5.9.2015

EN

Official Journal of the European Union

C 293/1

---

Euro exchange rates (1)

1

4 September 2015

(2015/C 293/01)

1 euro =

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,1138 |
| JPY | Japanese yen | 132,82 |
| DKK | Danish krone | 7,4604 |
| GBP | Pound sterling | 0,73150 |
| SEK | Swedish krona | 9,4147 |
| CHF | Swiss franc | 1,0839 |
| ISK | Iceland króna | |
| NOK | Norwegian krone | 9,2165 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 27,030 |
| HUF | Hungarian forint | 313,55 |
| PLN | Polish zloty | 4,2281 |
| RON | Romanian leu | 4,4308 |
| TRY | Turkish lira | 3,3167 |
| AUD | Australian dollar | 1,5948 |
| CAD | Canadian dollar | 1,4736 |
| HKD | Hong Kong dollar | 8,6321 |
| NZD | New Zealand dollar | 1,7478 |
| SGD | Singapore dollar | 1,5800 |
| KRW | South Korean won | 1 323,93 |
| ZAR | South African rand | 15,1744 |
| CNY | Chinese yuan renminbi | 7,0792 |
| HRK | Croatian kuna | 7,5590 |
| IDR | Indonesian rupiah | 15 787,71 |
| MYR | Malaysian ringgit | 4,7325 |
| PHP | Philippine peso | 52,076 |
| RUB | Russian rouble | 75,1586 |
| THB | Thai baht | 39,919 |
| BRL | Brazilian real | 4,2066 |
| MXN | Mexican peso | 18,7826 |
| INR | Indian rupee | 74,0625 |

Currency

Exchange rate

USD

US dollar

1,1138

JPY

Japanese yen

132,82

DKK

Danish krone

7,4604

GBP

Pound sterling

0,73150

SEK

Swedish krona

9,4147

CHF

Swiss franc

1,0839

ISK

Iceland króna

NOK

Norwegian krone

9,2165

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

27,030

HUF

Hungarian forint

313,55

PLN

Polish zloty

4,2281

RON

Romanian leu

4,4308

TRY

Turkish lira

3,3167

AUD

Australian dollar

1,5948

CAD

Canadian dollar

1,4736

HKD

Hong Kong dollar

8,6321

NZD

New Zealand dollar

1,7478

SGD

Singapore dollar

1,5800

KRW

South Korean won

1 323,93

ZAR

South African rand

15,1744

CNY

Chinese yuan renminbi

7,0792

HRK

Croatian kuna

7,5590

IDR

Indonesian rupiah

15 787,71

MYR

Malaysian ringgit

4,7325

PHP

Philippine peso

52,076

RUB

Russian rouble

75,1586

THB

Thai baht

39,919

BRL

Brazilian real

4,2066

MXN

Mexican peso

18,7826

INR

Indian rupee

74,0625

---

(1)  Source: reference exchange rate published by the ECB.

1

Source

---
| (a) | the                Quarterly Report on Form 10-QSB/A of the Company for the quarter                ended                March 31, 2007 (the “Report”), fully complies with the requirements of                Section 13(a) or 15(d)of the Securities Exchange Act of 1934; and |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (b) | the                information contained in the Report fairly presents, in all material                respects, the financial condition and results of operations of the                Company. |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  Dated:              January 28, 2008 |                                                                                                           |                               |
|--------------------------------------------|----------------------------------------------------------------------------------------------------------------|------------------------------------|
|                                       |                                                                                                           |                               |
|                                            |                                                                                                                | /s/ Darryl              Cohen |
|                                       | Darryl                Cohen, Chief                Executive Officer and Chief                Financial Officer |
|                                       |                                                                                                                |

----
IN THE SUPREME COURT OF PENNSYLVANIA

MIDDLE DISTRICT

COMMONWEALTH OF PENNSYLVANIA,

Respondent

v.

ANTHONY DION SHAW,

Petitioner :

:

:

:

:

:

:

:

:

:

: No. 582 MAL 2022

Petition for Allowance of Appeal

from the Order of the Superior Court

ORDER

PER CURIAM

AND NOW , this 31st day of May, 2023

, the Petition for Allowance of Appeal is

DENIED

.
#### State ex rel. Hasbrouck vs. The City of Milwaukee.

*Mandamus*— Form *of writ: Amendment.*

1. A *mandamus*must state the precise duty required; and an alternative writ commanding defendant to pay a judgment, *or*issue bonds for its payment, *or*levy a tax to pay it, is quashed.

2. Such a writ is amendable under our statute; and leave to amend is granted in this case.

*398Motion to quash an alternative *mandamus.*The form of the mandate will appear from the opinion.

*Emmons § Van Dyke,*for the motion.

*Palmer g Hooker, contra.*

Cole, J.

A motion is made to quash the alternative writ on various grounds, only one of which we deem it necessary to notice.

It is objected that the writ does not specify any particular duty to be performed, hut states several acts, and commands the respondents to perform one or the other of them, without designating which one they are required to perform.

The rule seems to he -well settled, that the mandatory clause of the writ should expressly state the duty required of the defendant. Tapping on Mandamus, *327; *State v. The Supervisors of Beloit,*20 Wis., 80. Here the command is, that the defendant pay the judgment therein mentioned, *or*issue.bonds for its payment, *or*proceed and levy a tax upon the taxable property of the city for its payment. These acts are distinct in their nature, and the defendant may not know which to perform.

The motion to quash, therefore, must prevail, with leave to the relator to amend the writ if he desires to do so. For we have no doubt but the writ is amendable under our statute.

*By the Court.*— Ordered accordingly.'
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in section 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Child Health and Human Development Special Emphasis.                    

*Date:*                         April 21, 2015.                    

*Time:*                         1:00 p.m. to 4:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6100 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call).                    

*Contact Person:*                         Sathasiva B. Kandasamy, Ph.D., Scientific Review Officer, Scientific Review Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, 6100 Executive Boulevard, Room 5B01, Bethesda, MD 20892-9304, (301) 435-6680,                         *skandasa@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS)

Dated: March 20, 2015.

Michelle Trout,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2015-06843 Filed 3-24-15; 8:45 am]

 BILLING CODE 4140-01-P
Exhibit 32.1
 CERTIFICATIONS PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
  
    
    The Form 10-Q of the Company for the three months ended June 30, 2010 as filed with the
Securities and Exchange Commission on the date hereof (the Form 10-Q), fully complies
with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15
U.S.C. 78m or 78o(d)); and
    
    The information contained in the Form 10-Q fairly presents, in all material respects,
the financial condition and results of operations of the Company.
 /s/ Michael K. RobinsonMichael K. RobinsonChief Executive Officer, President and
Assistant Treasurer
#### Cady *against*Fairchild *and*Wife.

In an action of trespass in a *Justice's Court, where*there is a verdict and judgement for the defendant tje court, will not reverse judgment, because Against evidence, if it the injury was trivial, and the plaintiff e,¡t¡damages only, merely SUibr 13 “3ntsandvexa"

IN ERROR, on *certiorari,*to a Justice’s Court.

*^*7 . . . . *Lady*brought an action ot trespass against *Fairchild*and his *Wife,*who pleaded not guilty. The plaintiff and defendants lived under the same roof, occupying distinct parts of the house. The plaintiff, who had a lease for one year, removed with his family, and'the principal part of his furniture, before the expiration of the year, leaving a few old articles, of little value, in the apartment he had occupied. The defendants put the articles so left by the plain- * ,1 t *J*1 tiff, out of the house, where they remained for several days, and were then put back again by the defendants, without receiving any material injury. There was a trial by jury, and a verdict for the defendants, on which the justice gave judgment.

*Per Curiam.*

This is strictly a verdict contrary to evidence ; but as no more than *nominal*damages ought to have been given, no material injustice has been done ; and we ought to apply the rule which has been settled in regard *130to new trials In *Burton*v. *Thompson,*(2 *Burr. Rep.*664.) Lcmi *Mansfield*said, *“*it does not follow, by necessary consequence, that there must be a new trial granted in all cases whatsoever, where the verdict is contrary to evidence;’ as “ where there is no, real damage, and where the injury is so trivial as to not deserve above half a crown compensa-salion and a new trial was denied in that case, though it was admitted that the verdict was directly contrary to evidence.(a)

Though there is ground for a distinction between granting a new trial, and reversing a judgment, on return to a *certiorari;*yet, where the object of the plaintiff in error is merely *costs,*and to *vex*the defendant, we are justified in refusing to reverse the judgment. The judgment must, therefore, be affirmed.

Judgment *affirmed.**(b)*

(a)

**Vide *Hyatt*v. *Wood, 3 Johns. Rep.*239. *Fleming*v. *Gilbert, Ib.*528. *Feeter*v. *Whipple,*8 *Johns. Rep.*369.

(b)

**A *certiorari*lies to reverse a judgment of nonsuit, where costs are awarded against the plaintiff. *(Smith*v. *Sults,*2 *Johns. Rep.*9.)
Exhibit
32.01




CERTIFICATION
PURSUANT TO


18
U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002




In
connection with the Quarterly Report of Sangui Biotech International, Inc. (the
“Company”) on Form 10-QSB for the period ending March 31, 2008 as filed
with the Securities and Exchange Commission on the date hereof (the “Report”),
I, Thomas Striepe, Chief Executive Officer, and I, Joachim Fleing, Chief
Financial Officer of the Company, certify, pursuant to 18 U.S.C.
§ 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of
2002, that, to the best of my knowledge and belief:




(1)        The
Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and




(2)        The
information contained in the Report fairly presents, in all material respects,
the financial condition and result of operations of the Company.








Dated: August 25,
2008   /s/
Thomas Striepe


__________________________________________


By:
Thomas Striepe


Chief
Executive Officer






Dated: August 25,
2008   /s/
Joachim Fleing
 __________________________________________
 By:
Joachim Fleing
 Chief
Financial Officer








A
signed original of this written statement required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the electronic version of this written statement
has been provided to the Company and will be retained by the Company and
furnished to the Securities and Exchange Commission or its staff upon
request.
II 

Calendar No. 138 

117TH CONGRESS 

1ST SESSION S. 2868 

To temporarily extend the public debt limit until December 16, 2022. 

IN THE SENATE OF THE UNITED STATES 

SEPTEMBER 28, 2021 

Mr. SCHUMER introduced the following bill; which was read the first time 

SEPTEMBER 29, 2021 

Read the second time and placed on the calendar 

A BILL 

To temporarily extend the public debt limit until December 

16, 2022. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. TEMPORARY EXTENSION OF PUBLIC DEBT 

4 LIMIT. 

5 (a) IN GENERAL.—Section 3101(b) of title 31, 

6 United States Code, shall not apply for the period begin7 ning on the date of enactment of this Act and ending on 

8 December 16, 2022. 


pbinns on DSKJLVW7X2PROD with BILLS
2 

•S 2868 PCS

1 (b) SPECIAL RULE RELATING TO OBLIGATIONS

2 ISSUED DURING EXTENSION PERIOD.—Effective on De3 cember 17, 2022, the limitation in effect under section 

4 3101(b) of title 31, United States Code, shall be increased 

5 to the extent that— 

6 (1) the face amount of obligations issued under 

7 chapter 31 of such title and the face amount of obli8 gations whose principal and interest are guaranteed 

9 by the United States Government (except guaran10 teed obligations held by the Secretary of the Treas11 ury) outstanding on December 17, 2022, exceeds 

12 (2) the face amount of such obligations out13 standing on the date of enactment of this Act. 

14 (c) EXTENSION LIMITED TO NECESSARY OBLIGA15 TIONS.—An obligation shall not be taken into account 

16 under subsection (b)(1) unless the issuance of such obliga17 tion was necessary to fund a commitment incurred pursu18 ant to law by the Federal Government that required pay19 ment before December 17, 2022. 


pbinns on DSKJLVW7X2PROD with BILLS

pbinns on DSKJLVW7X2PROD with BILLS
Calendar No. 138 

117TH CONGRESS 

1ST SESSION S. 2868 

A BILL 

To temporarily extend the public debt limit until 

S

December 16, 2022. 

EPTEMBER 29, 2021 

Read the second time and placed on the calendar 


pbinns on DSKJLVW7X2PROD with BILLS
#### Diane Pizarro, Appellant, v Evergreen Estates Housing, Respondent.

[772 NYS2d 508]

Order, Supreme Court, Bronx County (Bertram Katz, J.), entered October 29, 2001, which, in an action for personal injuries, denied plaintiffs motion to vacate the Clerk’s dismissal of the action, and to restore it to the trial calendar, unanimously affirmed, without costs. Appeal from order, same court and Justice, entered December 2, 2002, which denied plaintiffs motion to renew and reargue, deemed to be from an order denying a motion only to reargue, and, so considered, the appeal therefrom unanimously dismissed, without costs, as taken from a nonappealable order.

Plaintiff fails to show a reasonable excuse for the default that led to the Clerk’s dismissal of the action (22 NYCRR 202.21 [f]; *see Alvarado v 1824 Weeks Ave. Equities,*305 AD2d 118 [2003]). It appears that personal appearances were not required at the Clerk’s calendar call in question, and that instead the Clerk was to be advised of the status of the action through the submission of a written form. Plaintiff’s attorney asserts that his office completed the form and returned it to the court in timely fashion through its lawyers’ service. However, he submits no documentary evidence showing that the form was either received by the lawyers’ service or delivered to the court. Plaintiffs motion to renew and reargue raised no new facts and *144is therefore properly viewed as one for reargument only, the denial of which is not appealable *(see Lichtman v Mount Judah Cemetery,*269 AD2d 319, 320 [2000], *lv denied in part and dismissed in part*95 NY2d 860 [2000]). Concur—Nardelli, J.P., Andrias, Sullivan and Lerner, JJ.